Medicine
Ticagrelor 90 mg tablet
Ticagrelor 90 mg tablet is a generic prescription medicine for oral use, made by 28 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Ticagrelor
- Brand
- Sold under the generic name
- Strength
- 90 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 100 tablets, 60 tablets and 68 more
- Manufacturers
- Alembic PharmaceuticalsIndiaLaurus LabsIndiaMicro LabsIndiaNovadoz PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaCiplaIndiaAscend LaboratoriesIndiaLifestar PharmaIndiaMacleods PharmaceuticalsIndiaAiPing Pharmaceutical28 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AC24 Ticagrelor
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 April 2020
- Identifiers
- RxCUI 1116635, 1666332DailyMed set ID 41c5d35c-91de-a8a4-e063-6394a90ac5ff, b1c29d47-960f-4fc4-b6ff-399e2c6eec4c, 32ebf046-73e4-b11b-e063-6294a90a5bf4 +28NDC 71610-958, 72205-368, 73190-008 +28Application ANDA208584, ANDA208596, ANDA208576 +15
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 28 labelers. The register lists 71 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 46708-241-30 | Alembic PharmaceuticalsIndia | 1 May 2025 |
| 100 tablet, film coated in 1 bottle | 46708-241-31 | Alembic PharmaceuticalsIndia | 1 May 2025 |
| 60 tablet, film coated in 1 bottle | 46708-241-60 | Alembic PharmaceuticalsIndia | 1 May 2025 |
| 1000 tablet, film coated in 1 bottle | 46708-241-91 | Alembic PharmaceuticalsIndia | 1 May 2025 |
| 30 tablet, film coated in 1 bottle | 62332-241-30 | Alembic PharmaceuticalsIndia | 1 May 2025 |
| 100 tablet, film coated in 1 bottle | 62332-241-31 | Alembic PharmaceuticalsIndia | 1 May 2025 |
| 60 tablet, film coated in 1 bottle | 62332-241-60 | Alembic PharmaceuticalsIndia | 1 May 2025 |
| 1000 tablet, film coated in 1 bottle | 62332-241-91 | Alembic PharmaceuticalsIndia | 1 May 2025 |
| 500 tablet in 1 bottle | 67877-491-05 | Ascend LaboratoriesIndia | 5 March 2026 |
| 60 tablet in 1 bottle | 67877-491-60 | Ascend LaboratoriesIndia | 30 April 2025 |
| 60 tablet, film coated in 1 package | 69097-991-03 | CiplaIndia | 1 May 2025 |
| 100 tablet, film coated in 1 package | 69097-991-07 | CiplaIndia | 1 May 2025 |
| 500 tablet, film coated in 1 package | 69097-991-12 | CiplaIndia | 1 May 2025 |
| 180 tablet in 1 bottle | 43598-480-18 | Dr. Reddy's LaboratoriesIndia | 30 April 2025 |
| 60 tablet in 1 bottle | 43598-480-60 | Dr. Reddy's LaboratoriesIndia | 30 April 2025 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 43598-480-78 | Dr. Reddy's LaboratoriesIndia | 30 April 2025 |
| 1 blister pack in 1 carton / 10 tablet in 1 blister pack | 43598-480-79 | Dr. Reddy's LaboratoriesIndia | 30 April 2025 |
| 100 tablet in 1 bottle | 42385-994-01 | Laurus LabsIndia | 20 August 2026 |
| 500 tablet in 1 bottle | 42385-994-05 | Laurus LabsIndia | 20 August 2026 |
| 1000 tablet in 1 bottle | 42385-994-11 | Laurus LabsIndia | 20 August 2026 |
| 30 tablet in 1 bottle | 42385-994-30 | Laurus LabsIndia | 20 August 2026 |
| 60 tablet in 1 bottle | 42385-994-60 | Laurus LabsIndia | 20 August 2026 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 42385-994-68 | Laurus LabsIndia | 20 August 2026 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 42385-994-72 | Laurus LabsIndia | 20 August 2026 |
| 60 tablet, film coated in 1 bottle | 70756-048-60 | Lifestar PharmaIndia | 6 February 2026 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 70756-048-99 | Lifestar PharmaIndia | 6 February 2026 |
| 60 tablet, film coated in 1 bottle | 33342-432-09 | Macleods PharmaceuticalsIndia | 28 October 2025 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 33342-432-12 | Macleods PharmaceuticalsIndia | 28 October 2025 |
| 500 tablet, film coated in 1 bottle | 42571-263-05 | Micro LabsIndia | 1 November 2026 |
| 1000 tablet, film coated in 1 bottle | 42571-263-10 | Micro LabsIndia | 1 November 2026 |
| 100 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 42571-263-11 | Micro LabsIndia | 1 November 2026 |
| 60 tablet, film coated in 1 bottle | 42571-263-60 | Micro LabsIndia | 1 November 2026 |
| 180 tablet, film coated in 1 bottle | 42571-263-64 | Micro LabsIndia | 1 November 2026 |
| 10 blister pack in 1 box, unit-dose / 10 tablet in 1 blister pack | 72205-368-11 | Novadoz PharmaceuticalsIndia | 1 May 2025 |
| 180 tablet in 1 bottle | 72205-368-18 | Novadoz PharmaceuticalsIndia | 1 May 2025 |
| 60 tablet in 1 bottle | 72205-368-60 | Novadoz PharmaceuticalsIndia | 1 May 2025 |
| 100 tablet in 1 bottle | 72205-368-91 | Novadoz PharmaceuticalsIndia | 1 May 2025 |
| 1000 tablet in 1 bottle | 72205-368-99 | Novadoz PharmaceuticalsIndia | 1 May 2025 |
| 100 tablet in 1 bottle | 11788-158-01 | AiPing Pharmaceutical | 10 June 2026 |
| 60 tablet in 1 bottle | 11788-158-60 | AiPing Pharmaceutical | 10 June 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ticagrelor 90 mg tablet.
Other strengths and forms of Ticagrelor
Clinical summary
Ticagrelor is a P2Y12 platelet inhibitor indicated to reduce the risk of cardiovascular (CV) death, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Ticagrelor for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TicagrelorFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- BRILINTA prescribing information (AstraZeneca Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Brilique: European public assessment report (EPAR) · European Medicines Agency
Need Ticagrelor 90 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.